Skip to main content
Log in

Efficacy of slow-release nifedipine on ischemic attacks in patients with variant angina

  • Nifedipine, Cardioprotection, and Ischemic Heart Disease
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

We examined the effects of slow-release nifedipine on ischemic attacks in eight patients with variant angina. The study period was divided into four parts: placebo I period; nifedipine I period, when 20-mg slow-release nifedipine was given once a day at 10:00 p.m.; placebo II period; and nifedipine II period, when 20-mg slow-release nifedipine was given twice a day at 10:00 p.m. and 6:00 a.m. Each period consisted of 4 days, and 48-hour Holter monitoring was done at the end of each period. There was a significant decrease in the number of the episodes per 48 hours during the nifedipine I and nifedipine II periods as compared with the placebo I period (2.4±2.2 vs. 25.7±12.3, p<0.01; and 0.1±0.1 vs. 25.7±12.3, p<0.01, respectively). The total duration of episodes of ST-segment elevation per 48 hours decreased significantly during the nifedipine I period and the nifedipine II period as compared with the placebo I period (2.4±2.2 vs. 87.6±30.2 minutes, p<0.01; and 0.3±0.3 vs. 87.6±30.2 minutes, p<0.01, respectively). The total duration of the episodes also decreased significantly during the nifedipine II period as compared with the placebo II period (0.3±0.3 vs. 31.6±20.1 minutes, p<0.05).

We concluded that 20-mg slow-release nifedipine given once a day at 10:00 p.m., or twice a day at 10:00 p.m. and 6:00 a.m., is highly effective in suppressing ischemic episodes in patients with variant angina.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yasue H. Pathophysiology and treatment of coronary arterial spasm.Chest 1980;78(Suppl):216–223.

    PubMed  CAS  Google Scholar 

  2. Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography.N Engl J Med 1973;228:745–751.

    Article  Google Scholar 

  3. Yasue H, Touyama M, Kato H, et al. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: Documentation by coronary arteriography.Am Heart J 1976;91:148–155.

    PubMed  CAS  Google Scholar 

  4. Hillis LD, Braunwald E. Coronary artery spasm.N Engl J Med 1978;299:695–702.

    Article  PubMed  CAS  Google Scholar 

  5. Maseri A, Severi S, De Nes M, et al. “Variant” angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia.Am J Cardiol 1978;42:1019–1035.

    Article  PubMed  CAS  Google Scholar 

  6. Yasue H, Omote S, Takizawa A, et al. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review.Circ Res 1983;52(Suppl I):147–152.

    Google Scholar 

  7. Antman E, Muller J, Goldberg S, et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.N Engl J Med 1980;302:1269–1273.

    Article  PubMed  CAS  Google Scholar 

  8. Braunwald E. Mechanism of action of calcium-channel-blocking agents.N Engl J Med 1982;307:1618–1627.

    Article  PubMed  CAS  Google Scholar 

  9. Rämsch K-D, Ziegler R. Plasma concentrations of various nifedipine formulations in healthy volunteers. In6th International Adalat Symposium, Genera, April 18–20, 1985. Monograph. Amsterdam: Excerpta Medica, 1986:23–32.

    Google Scholar 

  10. Kleinbloesem CH, van Brummelen P, van de Linde JA, et al. Nifedipine: Kinetics and dynamics in healthy subjects.Clin Pharmacol Ther 1984;35:742–749.

    Article  PubMed  CAS  Google Scholar 

  11. Taburet AM, Singlas E, Colin JN, et al. Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.Hypertension 1983;5(Suppl II):II29-II33.

    PubMed  CAS  Google Scholar 

  12. Waters DD, Miller DD, Bouchard A, et al. Circadian variation in variant angina.Am J Cardiol 1984;54:61–64.

    Article  PubMed  CAS  Google Scholar 

  13. Shank SJ, Pepine CJ. Transient asymptomatic S-T segment depression during daily activity.Am J Cardiol 1977;39:396–402.

    PubMed  Google Scholar 

  14. Deanfield JE, Maseri A, Selwyn AP, et al. Myocardial ischemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes.Lancet 1983;2:753–758.

    Article  PubMed  CAS  Google Scholar 

  15. Cecchi AC, Dovellini EV, Marchi F, et al. Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina.J Am Coll Cardiol 1983;1:934–939.

    Article  PubMed  CAS  Google Scholar 

  16. Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm.Circulation 1986;74:955–963.

    PubMed  CAS  Google Scholar 

  17. Okumura K, Yasue H, Horio Y, et al. Multivessel coronary spasm in patients with variant angina: A study with intracoronary injection of acetylcholine.Circulation 1988; 3:535–542.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasue, H., Morikami, Y. Efficacy of slow-release nifedipine on ischemic attacks in patients with variant angina. Cardiovasc Drug Ther 4 (Suppl 5), 915–918 (1990). https://doi.org/10.1007/BF02018292

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018292

Key Words

Navigation